Nanocarrier-enhanced intracellular delivery of benznidazole for treatment of Trypanosoma cruzi infection.

JCI Insight · 2021 · PMC8262286 · PMID 33986194

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The group receiving the extremely low dose of 0.03 mg/kg BNZ-PSs showed a 50% reduction in parasitemia, but the difference from untreated controls did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.